# US 2013/0157956 A1 · Biocompatible compositions for tissue augmentation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157956 A1
- Document ID: US20130157956A1
- Status: Published application
- Kind: A1
- Application number: 13/818,760
- Filed: 2011-08-12
- Published: 2013-06-20
- Earliest claimed: 2010-08-31
- Assignees: Fujifilm Manufacturing Europe B.V.
- Inventors: Sebastianus Gerardus Kluijtmans; Annemarie Tuin; Marja Johanna Adriana Van Luyn; Martin Conrad Harmsen; Jan Bastiaan Bouwstra
- Web page: https://patentgrep.com/patent/US20130157956A1

## CPC

- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/222: {Gelatin}
- A61L 27/48: with macromolecular fillers
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

A crosslinked gelatin hydrogel composition for tissue augmentation.

## Claims

### Claim 1

A biocompatible composition for tissue augmentation comprising crosslinked recombinant gelatin-like protein and crosslinked hyaluronic acid, wherein the recombinant gelatin-like protein is free of homo- or heterotrimeric structures and wherein the mass ratio between the recombinant gelatin-like protein and the hyaluronic acid is in the range of from 60:40 to 5:95 and wherein the in vivo degradation time of the composition is at least 1 month.

### Claim 2 (depends on 1)

The composition according to claim 1 wherein the recombinant gelatin-like protein comprises at least 0.3 mmol/g lysine and/or hydroxylysine residues before cross-linking and at least 0.15 mmol/g free amines after cross-linking.

### Claim 3 (depends on 1)

The composition according to claim 1 wherein the recombinant gelatin-like protein is free of hydroxylated amino acid residues.

### Claim 4 (depends on 1)

The composition according to claim 1 wherein the recombinant gelatin-like protein comprises at least one RGD motif.

### Claim 5 (depends on 1)

The composition according to claim 1 wherein the overall mass ratio of the recombinant gelatin-like protein to hyaluronic acid is at least 10:90.

### Claim 6 (depends on 1)

The composition according to claim 1 wherein the cross-linked recombinant gelatin-like protein fraction has a higher in vivo degradation time then the crosslinked hyaluronic fraction.

### Claim 7 (depends on 1)

The composition according to claim 1 wherein the composition is biphasic wherein one phase comprises crosslinked recombinant gelatin-like protein and the other phase comprises crosslinked hyaluronic acid.

### Claim 8 (depends on 1)

A method for preparing a composition as described in claim 1 comprising:
(a) crosslinking a hyaluronic acid composition to give a hydrogel;
(b) adding a solution comprising recombinant gelatin-like protein and a gelatin crosslinking agent to the hyaluronic acid hydrogel;
(c) mixing of the hydrogel and the gelatin and a gelatin crosslinking agent solution; and
(d) allowing the mixture to crosslink and form a biphasic hydrogel.

### Claim 9 (depends on 1)

The use of a composition as described in claim 1 as a dermal filler.

### Claim 10 (depends on 1)

The use of a composition as described in claim 1 as a localised fibroblast attractant

### Claim 11 (depends on 1)

The use of a composition as described in claim 1 to induce the deposition of autologous collagen.
